Tom Wilemon

Study that investigated whether three smoking cessation drugs could reduce alcohol intake yields unexpected finding

A Vanderbilt study of three proven smoking cessation treatments suggests these medications could play an important role to reduce alcohol use and smoking at the same time.

Study reveals need for matching targeted therapies with EGFR subtypes

A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.

Holowatyj named chair of scientific advisory board for ACPMP Research Foundation

Vanderbilt’s Andreana Holowatyj, PhD, MSCI, has been named the inaugural chair of the scientific advisory board for the Appendix Cancer Pseudomyxoma Peritonei Research Foundation.

Smokers have better quit rates with hospital-based interventions than quitline help, but study indicates need for longer follow-up

A health care system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline, but the advantage disappeared at six months when both treatments produced comparable quit rates, researchers have found.